AQP1- A regulatory factor associated with brown adipose tissue silencing

Chloe Cheng,Christopher Blay,Pei-Yin Tsai,Muying Li,Kaydine Edwards,Yue Qu,Yang Liu,Nina Buettner,Claire Walter,Mary Snyder,Ines Costa,Oliver Devuyst,Joeva J Barrow
DOI: https://doi.org/10.1101/2024.09.23.614599
2024-09-25
Abstract:The activation of non-shivering thermogenesis (NST) in brown adipose tissue (BAT) by environmental cold challenge yields strong metabolic benefit in the face of diet-induced obesity (DIO). Yet, a critical barrier to leveraging brown fat NST for therapeutic use against metabolic disease is that BAT is silenced and inactive at physiological ambient temperature conditions in humans. The mechanisms that govern this silencing process remain poorly understood. Here, we identified a putative BAT-silencing factor, aquaporin-1 (AQP1), in brown fat from wild-type (WT) mice via proteomics analysis. We generated the first BAT-specific AQP1 knockout mice (AQP1-KO) and revealed that AQP1-KO could activate NST under BAT silencing environmental conditions and that the AQP1-KO mice were significantly protected against DIO and metabolic dysfunction compared to Flox controls. We found that AQP1-KO mice on high fat diet (HFD) had reduced weight gain through reductions in fat mass, improved glucose tolerance, and increased whole body energy expenditure compared to Flox control mice. Mechanistically, we show that AQP1 ablation in mice had upregulated gene expression related to the electron transport chain (ETC) and mitochondrial translation contributing to the activation of NST under BAT environmental silenced conditions.
Molecular Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is **the unclear silencing mechanism of brown adipose tissue (BAT) under physiological temperature conditions**. Specifically, although the non - shivering thermogenesis (NST) that activates BAT has significant metabolic benefits for treating diet - induced obesity (DIO), human BAT is usually silent and inactive under physiological ambient temperature, which limits its potential as a means of treating metabolic diseases. Therefore, understanding and regulating the mechanism of BAT silencing is crucial for developing new treatments for obesity and related metabolic diseases. Through proteomic analysis, the paper discovered a regulatory factor that may be related to BAT silencing - aquaporin - 1 (AQP1). The authors generated the first BAT - specific AQP1 knockout mouse model (AQP1 - KO) and found that these mice were able to activate NST under physiological temperature conditions, and compared with control group mice, AQP1 - KO mice showed significantly reduced weight gain, improved glucose tolerance, and increased overall energy consumption under high - fat diet conditions. These results indicate that AQP1 may play a key role in BAT silencing, and its knockout can be an effective strategy to combat metabolic dysfunction caused by obesity.